Press Releases

For media inquiries and material requests please reach media@rewalk.com

ReWalk Robotics Ltd. — February 13, 2019

ReWalk Announces Cigna as First Private US. Insurer to Adopt National Policy Change for Coverage of Personal Exoskeleton Devices

Cigna Transitions to Case-by-Case Review Process, Eliminating Non-Coverage Policy MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, Feb. 13, 2019 — ReWalk Robotics, Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”), disclosed today that Cigna Corporation (NYSE:CI), a leading global health service company, has revised its policy regarding coverage...

Read more

ReWalk Robotics Ltd. — November 15, 2018

United Spinal Association Issues Recommendation for Insurers to Consider Powered Exoskeleton Devices Medically Necessary for Paralyzed Individuals

Recommendation points to health benefits, safety of exoskeletons for all qualified spinal cord injured users MARLBOROUGH, MA / YOKNEAM ILIT, ISRAEL – ReWalk Robotics, Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) applauds United Spinal Association’s recommendation, dated November 9,...

Read more

ReWalk Robotics Ltd. — November 9, 2018

ReWalk Announces Placement of 500th Exoskeleton System

Robotic exoskeleton manufacturer has provided life changing medical devices for persons with spinal cord injury in 26 countries MARLBOROUGH, MA / YOKNEAM ILIT, ISRAEL – ReWalk Robotics, Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) announced today that the company...

Read more

ReWalk Robotics Ltd. — July 20, 2018

U.S. Department of Veterans Affairs Expands Access to ReWalk Exoskeletons for Paralyzed Veterans with Revised National Policy

Updated VA policy provides expanded access for training to additional VA centers and private rehabilitation clinics through the Veterans Choice Program MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, July 20, 2018 /PRNewswire/ — ReWalk Robotics, Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) announced that the U.S. Department of...

Read more

ReWalk Robotics Ltd. — April 3, 2018

ReWalk Launches Clinical Study for Its ReStore Soft Exo-Suit System

Study of new powered soft exo-suit for stroke rehabilitation is intended to provide clinical data for upcoming FDA submission MARLBOROUGH, MA / YOKNEAM ILIT, ISRAEL – ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”), a leading manufacturer of robotic...

Read more